entertainment -WSS

entertainment

author：entertainment 2025-10-01 00:59:26 - browse：9648

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Beach reads and more: STAT's 2023 summer book list

WSS

Study: Pain burden is higher in Black NFL players than white ones

A deep dive into Applied Therapeutics’ data, and questions on Cassava

What to know about OceanGate, the company behind the missing Titanic submersible

N.Y. state detects polio case, first in the U.S. since 2013

Change Healthcare cyberattack prompts Medicare loan program

The Readout: Amylyx, Alumis, and Lundbeck drug updates

entertainment

entertainment

Wikipedia

What does generative AI mean for health care? We asked experts

How to bring more disabled researchers into academia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Palantir health business leans on meeting customers’ needs

New air purifier tech could be key to improving indoor air quality

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Guidelines to prevent youth baseball injuries need more muscle

Living with Fabry disease, a condition that causes chronic pain

Supreme Court strikes down use of affirmative action

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

focus

New research casts further doubt on a common procedure used with IVF

CDC marks new Covid

Retired US general questions alleged Putin, Prigozhin meeting

Lecanemab for Alzheimer's is coming. Is the health system ready?

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

leisure time

entertainment

leisure time

entertainment